WINDSOR, ONTARIO, CANADA, July 9, 2021 /EINPresswire.com/ — Emergence Global Enterprises Inc. (“Emergence Global” or the “Company”) (CSE: EMRG) (OTCQB: ELOAF), an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands, is pleased to announce that it has completed the payment of shares for services rendered to the Company by professional and advisory staff from November 2019 to April 2021. During this period, the Company relied on Consultants and Advisors to provide services as the Company had no employees at that time. A total of 8.05 million shares are being distributed as part of this issuance to satisfy the consulting agreements for the period of November 2019 to April 2021.
The Company is announcing that Bahige (Bill) Chaaban is stepping down as President to focus on leading our Mergers and Acquisitions plan. Bill will continue to serve as a Director of the Corporation. Joseph Byrne will assume responsibility as President & CEO effective immediately.
On April 12, 2021, the Company announced the recruitment and hiring of its Management Team and finalized its Board of Directors structure. The current members of the Board are Joseph Byrne, Chair; Brian Payne, Secretary; Diego Rodriguez, Treasurer; and Directors Bahige Chaaban, Cameron Canzellerini and Christian Gallant.
Additional information about the Company can be found on SEDAR under the Issuer Profile of “Emergence Global Enterprises Inc.” or on OTC MARKETS.
About the Company
Emergence Global Enterprises Inc. (“Emergence”) is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Emergence has become a North American developer and distributor of branded natural health foods, supplements and sports nutrition specialty supplements. The Company is currently considering several development projects.
For further information on the Company, please contact: Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: firstname.lastname@example.org.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) or OTC Markets accepts responsibility for the adequacy or accuracy of this press release.